Related Experiment Video
Updated: Sep 26, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferon-induced sarcoidosis
Ami N Rubinowitz1, David P Naidich, Cesar Alinsonorin
1the Department of Radiology, New York University Medical Center, New York, NY 10016, USA. ami.rubinowitz@med.nyu.edu
Abstract:
Interferons have been used as therapy of both malignant and nonmalignant diseases and commonly in the treatment of hepatitis C virus infection. Although the most commonly encountered side effects of interferon therapy include nonspecific constitutional symptoms, pulmonary involvement is rare. Here, we provide two documented cases of sarcoidosis appearing in patients receiving interferon therapy for hepatitis C infection, because there have only been a few reports of this association. Physicians should be aware of this uncommon yet clinically important complication, because imaging these patients may obviate more invasive procedures.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Chronic Inflammation: Introduction
Respiratory Syncytial Virus Disease
Type I Diabetes II: Pathophysiology
Hypersensitivity Reactions: Immune-Complex Reactions
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...